1. Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis 
Virendra Singh, Amarjit Keisham, Ashish Bhalla, Navneet Sharma, Ritesh Agarwal, Ratiram Sharma, Akash Singh 
Clinical Gastroenterology and Hepatology 
Volume 16, Issue 10, Pages e2 (October 2018)
DOI: /j.cgh
Copyright © 2018 AGA Institute Terms and Conditions

2. Figure 1
Kaplan-Meier curve showing the cumulative probability of survival at day 90 of patients treated with granulocyte colony-stimulating factor (G-CSF), combination, and standard medical therapy (control). The difference between the 3 groups was statistically significant (P < .001, log-rank test). There was better 90-day survival in the G-CSF group and combination group compared with SMT (P = and .037, respectively). However, there was no significant difference in 90-day survival between the combination and G-CSF groups (P = .112). NAC, N-acetylcysteine.
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

3. Supplementary Figure 1
Study design and flow diagram of patients’ selection. G-CSF, granulocyte colony-stimulating factor; NAC, N-acetylcysteine; SMT, standard medical therapy.
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions